Recent Advances in Cancer Immunotherapy Delivery Modalities

被引:12
|
作者
Muthukutty, Palaniyandi [1 ]
Woo, Hyun Young [2 ,3 ]
Ragothaman, Murali [1 ]
Yoo, So Young [1 ]
机构
[1] Pusan Natl Univ, BIOIT Foundry Technol Inst, Busan 46241, South Korea
[2] Pusan Natl Univ Hosp, Dept Internal Med, Busan 49241, South Korea
[3] Pusan Natl Univ Hosp, Med Res Inst, Busan 49241, South Korea
关键词
drug delivery; cancer immunotherapy; CAR-T cells; nanoparticles; INJECTABLE POLYPEPTIDE HYDROGEL; COLONY-STIMULATING FACTOR; ONCOLYTIC VACCINIA VIRUS; MODIFIED T-CELLS; DRUG-DELIVERY; CO-DELIVERY; ANTITUMOR IMMUNITY; TUMOR-GROWTH; PHASE-II; IN-VIVO;
D O I
10.3390/pharmaceutics15020504
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Immunotherapy is crucial in fighting cancer and achieving successful remission. Many novel strategies have recently developed, but there are still some obstacles to overcome before we can effectively attack the cancer cells and decimate the cancer environment by inducing a cascade of immune responses. To successfully demonstrate antitumor activity, immune cells must be delivered to cancer cells and exposed to the immune system. Such cutting-edge technology necessitates meticulously designed delivery methods with no loss or superior homing onto cancer environments, as well as high therapeutic efficacy and fewer adverse events. In this paper, we discuss recent advances in cancer immunotherapy delivery techniques, as well as their future prospects.
引用
收藏
页数:24
相关论文
共 50 条
  • [21] Advances in Engineering Cells for Cancer Immunotherapy
    Xu, Xiao
    Li, Teng
    Shen, Shiyang
    Wang, Jinqiang
    Abdou, Peter
    Gu, Zhen
    Mo, Ran
    THERANOSTICS, 2019, 9 (25): : 7889 - 7905
  • [22] Recent advances in drug delivery strategies for treatment of ovarian cancer
    Zahedi, Payam
    Yoganathan, Roshan
    Piquette-Miller, Micheline
    Allen, Christine
    EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (05) : 567 - 583
  • [23] Recent Advances in the Development of Membrane-derived Vesicles for Cancer Immunotherapy
    Xiao, Yuai
    Wu, Minliang
    Xue, Chunyu
    Wang, Yuchong
    CURRENT DRUG DELIVERY, 2023, 21 (03) : 403 - 420
  • [24] Role of Different Peptides for Cancer Immunotherapy
    Luthra, Ritika
    Datta, Shreeja
    Roy, Arpita
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (04) : 2777 - 2793
  • [25] Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
    Sun, Xiangyu
    Zhao, Ping
    Lin, Jierou
    Chen, Kun
    Shen, Jianliang
    CANCER DRUG RESISTANCE, 2023, 6 (02) : 390 - 415
  • [26] Recent advances in nanomedicine-based delivery of histone deacetylase inhibitors for cancer therapy
    Hafez, Dina A.
    Hassanin, Islam A.
    Teleb, Mohamed
    Khattab, Sherine N.
    Elkhodairy, Kadria A.
    Elzoghby, Ahmed O.
    NANOMEDICINE, 2021, 16 (25) : 2305 - 2325
  • [27] Recent progress in cancer immunotherapy approaches based on nanoparticle delivery devices
    Gupta, Biki
    Kim, Jong Oh
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2021, 51 (04) : 399 - 412
  • [28] Recent progress in cancer immunotherapy approaches based on nanoparticle delivery devices
    Biki Gupta
    Jong Oh Kim
    Journal of Pharmaceutical Investigation, 2021, 51 : 399 - 412
  • [29] Recent Advances and Challenges in Cancer Immunotherapy
    Peterson, Chelsea
    Denlinger, Nathan
    Yang, Yiping
    CANCERS, 2022, 14 (16)
  • [30] Nanoscale delivery systems for cancer immunotherapy
    Wang, Zejun
    Liu, Wenhan
    Shi, Jiye
    Chen, Nan
    Fan, Chunhai
    MATERIALS HORIZONS, 2018, 5 (03) : 344 - 362